Has a currently accepted medical use in treatment in the United States. Has a low potential for abuse relative to those in schedule 4. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Has a low potential for abuse relative to those in schedule 3. Abuse may lead to moderate or low physical dependence or high psychological dependence. What health professionals are involved in taking care of people who have coronary artery disease After a diagnosis of coronary artery disease (CAD).
Has a potential for abuse less than those in schedules 1 and 2. Abuse may lead to severe psychological or physical dependence. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. There is a lack of accepted safety for use under medical supervision. Has no currently accepted medical use in treatment in the United States. Is not subject to the Controlled Substances Act. This demonstrated a 60 mid-left-interior-descending stenosis (Figure 1) and fractional flow reserve of 0.85. He has a history of angina beginning 3 years ago, at which point he had coronary angiography. The schedule may depend on the exact dosage form or strength of the medication. A 60-year-old man with known chronic coronary artery disease (CAD) is referred to you because of an abnormal stress test. Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. It is usually caused by atherosclerosis which is a. There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. Coronary artery disease (CAD) is a condition which affects the arteries that supply the heart with blood. This medication may not be approved by the FDA for the treatment of this condition.Īn Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.Īdequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).Īnimal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.Īnimal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. If you developed cardiac risk factors during pregnancy, such as diabetes or hypertension, that can increase your risk of heart attack in the future, we will work with you to manage those risk factors after the baby is born.For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).Īctivity is based on recent site visitor activity relative to other medications in the list. Our cardiologists work with Stanford’s OB/GYN Partners for Health to guide you safely through your pregnancy. Some women can develop cardiac issues during pregnancy that require specialized expertise to manage. If you are on any medications for CAD and are pregnant, are planning to become pregnant, or are breastfeeding, our cardiologists work with the doctors at Stanford’s Gynecology Clinic to ensure that the drugs you are using are safe for you and your baby.
At Stanford, we have the tools, technology, and knowledge to find these conditions and provide women with an accurate diagnosis so you can start getting the proper treatment right away. Many women with hard-to-detect forms of non-obstructive CAD may have gone to doctors at other clinics without getting a precise diagnosis. Insignificant coronary artery disease patients were younger, more often female, and had less cardiac risk factors than CAD patients.